ПРЕПРИНТ
О результатах, изложенных в препринтах, не следует сообщать в СМИ как о проверенной информации.
Проведен анализ научных публикаций по вопросам основ патогенеза, лабораторной и рентгенологической картины пневмоний, а также вопросов ко-инфицирования у больных с SARS-CoV-2. На основе имеющихся в мировой научной литературе сведений дана оценка чувствительности методам компьютерной томографии и полимеразной цепной реакции. Наряду со сбором эпидемиологического анамнеза, обоснована необходимость применения как лабораторных, так и лучевых методов диагностики для наиболее достоверного выявления пациентов с новой коронавирусной пневмонией. Ключевые слова: SARS-CoV-2, пневмония, полимеразная цепная реакция, компьютерная томография, ко-инфекция
Базыкина Е. А., Троценко О. Е., Корита Т. В., Балахонцева Л. А., Котова В. О. 2020. ОСОБЕННОСТИ ПНЕВМОНИЙ, ВЫЗВАННЫХ НОВЫМ КОРОНАВИРУСОМ SARS-COV-2 (ОБЗОР ЛИТЕРАТУРЫ). COVID19-PREPRINTS.MICROBE.RU. https://doi.org/10.21055/preprints-3111730
1. Брико Н.И. 100 лет пандемии: уроки истории. Новый этап вакцинопрофилактики. Эпидемиология и вакцинопрофилактика. 2018; 4 (17): 68-75.
2. Jiang, F., Deng, L., Zhang, L. et al. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). J GEN INTERN MED 35, 1545–1549 (2020). https://doi.org/10.1007/s11606-020-05762-w.
3. Park J., Soyoung J., Aeran K., Park J. MERS transmission and risk factors: a systematic review. BMC Public Health (2018) 18:574; Wang, Yixuan et al. “Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. Journal of medical virology. vol. 92, 6 (2020): 568-576. doi:10.1002/jmv.25748.
4. Jin Y.H., Cai L., Cheng Z.S., et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4. doi:10.1186/s40779-020-0233-6.
5. Электронный ресурс. Дата обращения 18.07.2020 г. // www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions.
6. Wang Y., Wang Y., Chen Y., Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568-576. doi:10.1002/jmv.25748.
7. Hu Y., Deng H., Huang L., Xia L., Zhou X. Analysis of Characteristics in Death Patients with COVID-19 Pneumonia without Underlying Diseases. Acad Radiol. 2020;27(5):752. doi:10.1016/j.acra.2020.03.023.
8. García L.F. Immune Response, Inflammation, and the Clinical Spectrum of COVID-19. Front Immunol. 2020;11:1441. doi:10.3389/fimmu.2020.01441.
9. Lin L., Lu L., Cao W., Li T. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020;9(1):727-732. doi:10.1080/22221751.2020.1746199.
10. Li L., Zhang B., He B., Gong Z., Chen X. Critical patients with coronavirus disease 2019: Risk factors and outcome nomogram. J Infect. 2020;80(6):e37-e38. doi:10.1016/j.jinf.2020.03.025.
11. Wang F., Nie J., Wang H., et al. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis. 2020;221(11):1762-1769. doi:10.1093/infdis/jiaa150.
12. Liu Y., Yang Y., Zhang C., et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364-374. doi:10.1007/s11427-020-1643-8.
13. Liu X., Zhou H., Zhou Y., et al. Risk factors associated with disease severity and length of hospital stay in COVID-19 patients. J Infect. 2020;81(1):e95-e97. doi:10.1016/j.jinf.2020.04.008.
14. Li L., Zhang B., He B., Gong Z., Chen X. Critical patients with coronavirus disease 2019: Risk factors and outcome nomogram. J Infect. 2020;80(6):e37-e38. doi:10.1016/j.jinf.2020.03.025.
15. Porfidia A., Pola R. Venous thromboembolism in COVID-19 patients. J Thromb Haemost. 2020;18(6):1516-1517. doi:10.1111/jth.14842.
16. Guevara-Noriega K.A., Lucar-Lopez G.A., Nuñez G., Rivera-Aguasvivas L., Chauhan I. Coagulation Panel in Patients with SARS-CoV2 Infection (COVID-19). Ann Clin Lab Sci. 2020;50(3):295-298.
17. Wang F., Nie J., Wang H., et al. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis. 2020;221(11):1762-1769. doi:10.1093/infdis/jiaa150.
18. Du R.H., Liang L.R., Yang C.Q., et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55(5):2000524. Published 2020 May 7. doi:10.1183/13993003.00524-2020.
19. Póvoa HC.C., Chianca G.C., Iorio N.L.P.P. COVID-19: An Alert to Ventilator-Associated Bacterial. Infect Dis Ther. 2020;1-4. doi:10.1007/s40121-020-00306-5.
20. Yang X., Yu Y., Xu J., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481. doi:10.1016/S2213-2600(20)30079-5.
21. Wu J.H., Li X., Huang B., Su H., Li Y., Luo D.J., Chen S., Ma L., Wang S.H., Nie X., Peng L. [Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy]. Zhonghua Bing Li Xue Za Zhi. 2020;49(6):568-575.
22. Орлова, О.А., Акимкин, В. Г.. Организация эпидемиологической диагностики вентилятор-ассоциированных инфекций дыхательных путей. Медицинский алфавит. 2017; 3(30): 15-19.
23. Lansbury L., Lim B., Baskaran V., Lim W.S. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;S0163-4453(20)30323-6. doi:10.1016/j.jinf.2020.05.046.
24. Teng F., Liu X., Guo S.B., et al. Community-acquired bacterial co-infection predicts severity and mortality in influenza-associated pneumonia admitted patients. J Infect Chemother. 2019;25(2):129-136. doi:10.1016/j.jiac.2018.10.014.
25. Kreitmann L., Monard C., Dauwalder O., Simon M., Argaud L. Early bacterial co-infection in ARDS related to COVID-19. Intensive Care Med. 2020;1-3. doi:10.1007/s00134-020-06165-5.
26. Cucchiari D., Pericàs J.M., Riera J., et al. Pneumococcal superinfection in COVID-19 patients: A series of 5 cases. Med Clin (Barc). 2020;S0025-7753(20)30349-3. doi:10.1016/j.medcli.2020.05.022.
27. Chaudhary WA, Chong PL, Mani BI, et al. Primary Respiratory Bacterial Coinfections in Patients with COVID-19. Am J Trop Med Hyg. 2020;10.4269/ajtmh.20-0498. doi:10.4269/ajtmh.20-0498.
28. Hughes S., Troise O., Donaldson H., Mughal N., Moore L.S. Bacterial and fungal coinfection among hospitalised patients with COVID-19: A retrospective cohort study in a UK secondary care setting. Clin Microbiol Infect. 2020;S1198-743X(20)30369-4. doi:10.1016/j.cmi.2020.06.025.
29. Xia T., Li J., Gao J., Xu X. Small Solitary Ground-Glass Nodule on CT as an Initial Manifestation of Coronavirus Disease 2019 (COVID-19) Pneumonia. Korean J Radiol. 2020;21(5):545-549. doi:10.3348/kjr.2020.0240.
30. Zhou Y., Guo S., He Y., et al. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia. Front Cell Infect Microbiol. 2020;10:322. Published 2020 Jun 16. doi:10.3389/fcimb.2020.00322.
31. Song F., Shi N., Shan F., et al. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020;295(1):210-217. doi:10.1148/radiol.2020200274.
32. Shi H., Han X., Jiang N., et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425-434. doi:10.1016/S1473-3099(20)30086-4.
33. Pan Y., Guan H., Zhou S., et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. 2020;30(6):3306-3309. doi:10.1007/s00330-020-06731-x.
34. Sun R., Liu H., Wang X. Mediastinal Emphysema, Giant Bulla, and Pneumothorax Developed during the Course of COVID-19 Pneumonia. Korean J Radiol. 2020;21(5):541-544. doi:10.3348/kjr.2020.0180.
35. Wang J., Su X., Zhang T., Zheng C. Spontaneous Pneumomediastinum: A Probable Unusual Complication of Coronavirus Disease 2019 (COVID-19) Pneumonia. Korean J Radiol. 2020;21(5):627-628. doi:10.3348/kjr.2020.0281.
36. Tian X.L., Peng M., Wang H.P., Cai B.Q., Xu W.B., Zhu Y.J., Li T.S., Zhu H.D., Song L., Wang M.Z., Zhang L., Shi J.H. [The differential diagnosis for novel coronavirus pneumonia and similar lung diseases in general hospitals]. Zhonghua Jie He He Hu Xi Za Zhi. 2020 May 12;43(5):401-408. Chinese. doi: 10.3760/cma.j.cn112147-20200221-00136. PMID: 32153167.
37. Sun R., Liu H., Wang X. Mediastinal Emphysema, Giant Bulla, and Pneumothorax Developed during the Course of COVID-19 Pneumonia. Korean J Radiol. 2020;21(5):541-544. doi:10.3348/kjr.2020.0180.
38. Hase R., Kurita T., Muranaka E., Sasazawa H., Mito H., Yano Y. A case of imported COVID-19 diagnosed by PCR-positive lower respiratory specimen but with PCR-negative throat swabs. Infect Dis (Lond). 2020;52(6):423-426. doi:10.1080/23744235.2020.1744711.
39. Hornuss D., Laubner K., Monasterio C., Thimme R., Wagner D. COVID-19-assoziierte Pneumonie trotz persistierend negativen PCR-Tests aus oropharyngealen Abstrichen [COVID-19 associated pneumonia despite repeatedly negative PCR-analysis from oropharyngeal swabs]. Dtsch Med Wochenschr. 2020;145(12):844-849. doi:10.1055/a-1170-6061.
40. Lin C., Xiang J., Yan M., Li H., Huang S., Shen C. Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19). Clin Chem Lab Med. 2020;58(7):1089-1094. doi:10.1515/cclm-2020-0187.
41. Bhat R., Hamid A., Kunin J.R., et al. Chest Imaging in Patients Hospitalized With COVID-19 Infection - A Case Series. Curr Probl Diagn Radiol. 2020;49(4):294-301. doi:10.1067/j.cpradiol.2020.04.001.
42. Sivakorn C., Luvira V., Muangnoicharoen S., et al. Case Report: Walking Pneumonia in Novel Coronavirus Disease (COVID-19): Mild Symptoms with Marked Abnormalities on Chest Imaging. Am J Trop Med Hyg. 2020;102(5):940-942. doi:10.4269/ajtmh.20-0203.
43. Hase R., Kurita T., Muranaka E., Sasazawa H., Mito H., Yano Y. A case of imported COVID-19 diagnosed by PCR-positive lower respiratory specimen but with PCR-negative throat swabs. Infect Dis (Lond). 2020;52(6):423-426. doi:10.1080/23744235.2020.1744711.
44. Long C., Xu H., Shen Q., et al. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?. Eur J Radiol. 2020;126:108961. doi:10.1016/j.ejrad.2020.108961.
45. Lin C., Ding Y., Xie B., et al. Asymptomatic novel coronavirus pneumonia patient outside Wuhan: The value of CT images in the course of the disease. Clin Imaging. 2020;63:7-9. doi:10.1016/j.clinimag.2020.02.008.
46. Fechner C., Strobel K., Treumann T., et al. COVID-19 and the role of imaging: early experiences in Central Switzerland. Swiss Med Wkly. 2020;150:w20304. Published 2020 Jun 22. doi:10.4414/smw.2020.20304.
47. Zheng Z., Yao Z., Wu K., Zheng J. The diagnosis of pandemic coronavirus pneumonia: A review of radiology examination and laboratory test. J Clin Virol. 2020;128:104396. doi:10.1016/j.jcv.2020.104396.
48. Tenda E.D., Yulianti M., Asaf M.M., et al. The Importance of Chest CT Scan in COVID-19. Acta Med Indones. 2020;52(1):68-73.
49. Ai T., Yang Z., Hou H., et al. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020;296(2):E32-E40. doi:10.1148/radiol.2020200642.
50. Long C., Xu H., Shen Q., et al. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?. Eur J Radiol. 2020;126:108961. doi:10.1016/j.ejrad.2020.108961.
51. Fang Y., Zhang H., Xie J., et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology. 2020;296(2):E115-E117. doi:10.1148/radiol.2020200432.
52. Kang Z., Li X., Zhou S. Recommendation of low-dose CT in the detection and management of COVID-2019. Eur Radiol. 2020;30(8):4356-4357. doi:10.1007/s00330-020-06809-6.
53. Kim H. Outbreak of novel coronavirus (COVID-19): What is the role of radiologists?. Eur Radiol. 2020;30(6):3266-3267. doi:10.1007/s00330-020-06748-2.
